Drugs / FLUENZ
Trials 0
Also used as a comparator or background therapy in 1 trial
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 4 | NCT03502291 Comparator | Aug 2015 → May 2017 | influenza, pneumonia | Liverpool University Hospitals NHS Foundation Trust | Completed | No outcome recorded |
Evidence & citations 5 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | FLUENZ | “LAIV Nasal Spray: Inoculation (FLUMIST or FLUENZ) plus intramuscular placebo” NCT03502291 ↗ |
| Known as | FLUMIST | “LAIV Nasal Spray: Inoculation (FLUMIST or FLUENZ) plus intramuscular placebo” NCT03502291 ↗ |
| Known as | LAIV | ClinicalTrials.gov intervention name — accepted as the source's own label NCT03502291 ↗ |
| Modality | Vaccine | “The nasal spray is a live attenuated vaccine” NCT03502291 ↗ |
| Route | Intranasal | “LAIV Nasal Spray” NCT03502291 ↗ |